Conclusion
Tenofovir is a drug that is suspected less as a culprit drug during cutaneous eruptions as there are only limited reported cases. Tenofovir-induced LCV has been reported in 2 cases before this case report. Though cutaneous vasculitis is a less common adverse effect due to tenofovir, clinicians should be aware of this because timely diagnosis helps in the proper management of the patient.